Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central
nervous system (CNS). Microbes, including bacteria and certain viruses, particularly Epstein …

The human gut microbiome is well‐recognized as a key player in maintaining health.
However, it is a dynamic entity that changes across the lifespan. How the microbial changes …

A good nutritional status and healthy diets may decelerate disease disability and symptom
severity and quality of life of peoples with multiple sclerosis (MS). Mediterranean diet (MD) …

In the majority of cases, multiple sclerosis (MS) is characterized by reversible episodes of
neurological dysfunction, often followed by irreversible clinical disability. Accurate diagnostic …

Background Recent evidence has shown a significant association between menopause and
multiple sclerosis (MS) progression. This study investigated the possible role of menopause …

Abstract Objectives Neurofilament light chain (NfL) is an emerging biomarker of
neurodegeneration disorders. Knowledge of the biological variation (BV) can facilitate …

Background People over age 50–55 have historically been excluded from randomized
clinical trials for multiple sclerosis (MS). However, more than half of those living with an MS …

Background: Multiple sclerosis (MS) is a chronic autoimmune disease damaging the central
nervous system. Diminished inflammatory disease activities (DAs) as people with MS …

The anti-CD20 monoclonal antibody ocrelizumab reduces disability progression in primary
progressive multiple sclerosis. CD20 is a prototypical B-cell marker; however …

Brain and spinal cord imaging plays a pivotal role in aiding clinicians with the diagnosis and
monitoring of multiple sclerosis. Nevertheless, the significance of magnetic resonance …